1. CD271 determines migratory properties of melanoma cells
    Josefine Radke et al, 2017, Sci Rep CrossRef
  2. Clinical Application of Stem Cell Biology in Esophageal Cancer
    Tomoyuki Okumura et al, 2018 CrossRef
  3. Musashi1, a potential prognostic marker in esophageal squamous cell carcinoma
    Guohui Qin et al, 2017 CrossRef
  4. Enhanced cancer stem cell properties of a mitotically quiescent subpopulation of p75NTR-positive cells in esophageal squamous cell carcinoma.
    Hirofumi Kojima et al, 2017, Int J Oncol CrossRef
  5. Stochastic tuning of gene expression enables cellular adaptation in the absence of pre-existing regulatory circuitry
    Peter L Freddolino et al, 2018 CrossRef
  6. Cancer stem cells with increased metastatic potential as a therapeutic target for esophageal cancer
    D. Wang et al, 2017, Seminars in Cancer Biology CrossRef
  7. CD271 is a molecular switch with divergent roles in melanoma and melanocyte development
    Fabian V. Filipp et al, 2019, Sci Rep CrossRef
  8. Cancer stem cells in oesophageal squamous cell carcinoma: Identification, prognostic and treatment perspectives
    Farhadul Islam et al, 2015, Critical Reviews in Oncology/Hematology CrossRef
  9. Identification of melanoma initiating cells: does CD271 have a future?
    Robert Ballotti, 2015, Future Oncology CrossRef
  10. A literature mining-based approach for identification of cellular pathways associated with chemoresistance in cancer
    Jung Hun Oh et al, 2016, Brief Bioinform CrossRef
  11. Therapeutic implications of melanoma heterogeneity
    Stephanie J. Hachey et al, 2016, Exp Dermatol CrossRef
  12. Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma
    Jing He et al, 2016, J Exp Clin Cancer Res CrossRef
  13. Roles of different IRES-dependent FGF2 isoforms in the acquisition of the major aggressive features of human metastatic melanoma
    Elena Andreucci et al, 2017, J Mol Med CrossRef
  14. Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma
    Dhiraj Kumar et al, 2017, Mol Cancer CrossRef
  15. Relevance of Neurotrophin Receptors CD271 and TrkC for Prognosis, Migration, and Proliferation in Head and Neck Squamous Cell Carcinoma
    Yannick Foerster et al, 2019, Cells CrossRef
  16. Mesenchymal Stem Cells: A Hidden Arsenal for Mtb Persistence, Resuscitation, and Reactivation
    Jaishree Garhyan et al, 2019 CrossRef
  17. Zooming in across the Skin: A Macro-to-Molecular Panorama
    Ayşen Aslı Hızlı Deniz et al, 2019 CrossRef
  18. The Growing Impact of Micro/Nanomaterial‐Based Systems in Precision Oncology: Translating “Multiomics” Technologies
    Junrong Li et al, 2020, Adv. Funct. Mater. CrossRef
  19. Stem cell autocrine CXCL12/CXCR4 stimulates invasion and metastasis of esophageal cancer
    Xingwei Wang et al, 2017, Oncotarget CrossRef
  20. Linking Cancer Stem Cell Plasticity to Therapeutic Resistance-Mechanism and Novel Therapeutic Strategies in Esophageal Cancer.
    Chenghui Zhou et al, 2020, Cells CrossRef

  21. Insulin Reduces the Efficacy of Vemurafenib and Trametinib in Melanoma Cells


    Marta Osrodek et al, 2020, CMAR CrossRef
  22. Epigenetic Regulations of Cancer Stem Cells by the Aryl Hydrocarbon Receptor Pathway
    Sabah Akhtar et al, 2020, Seminars in Cancer Biology CrossRef
  23. Regulation of Formation, Stemness and Therapeutic Resistance of Cancer Stem Cells
    Nan Jing et al, 2021, Front. Cell Dev. Biol. CrossRef
  24. Targeting CD276 by CAR-T cells induces regression of esophagus squamous cell carcinoma in xenograft mouse models
    Yujing Xuan et al, 2021, Translational Oncology CrossRef
  25. Upregulation of CD271 transcriptome in breast cancer promotes cell survival via NFκB pathway.
    Nabiha Bashir et al, 2022, Mol Biol Rep CrossRef
  26. Specific Activation of the CD271 Intracellular Domain in Combination with Chemotherapy or Targeted Therapy Inhibits Melanoma Progression
    Annalisa Saltari et al, 2021, Cancer Res CrossRef
  27. Melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR-dependent mechanism.
    Susana García-Silva et al, 2021, Nat Cancer CrossRef
  28. m6A demethylase FTO promotes tumor progression via regulation of lipid metabolism in esophageal cancer
    Xiaoran Duan et al, 2022, Cell Biosci CrossRef
  29. mRNAsi-related genes can effectively distinguish hepatocellular carcinoma into new molecular subtypes
    Canbiao Wang et al, 2022, Computational and Structural Biotechnology Journal CrossRef
  30. Drug-Tolerant Persister Cells in Cancer Therapy Resistance
    Pavan Kumar Dhanyamraju et al, 2022 CrossRef
  31. Targeted surface marker screening on neuronal structures in the human choroid
    H. Wolfmeier et al, 2022, Experimental Eye Research CrossRef
  32. CD14, a novel surface marker of esophageal cancer stem cells
    Yonggang Lin et al, 2022, Oncol Rep CrossRef
  33. Biomarkers and signaling pathways of esophageal cancer stem cells: promising targets to limit the metastatic potential and stemness
    Onyisi Christiana Didamson et al, 2024 CrossRef
  34. “The accumulation of sphingosine kinase 2 disrupts the DNA damage response and promotes resistance to genotoxic agents”
    Gabriel da Silva et al, 2023, Gene CrossRef
  35. Potential markers of cancer stem-like cells in ESCC: a review of the current knowledge
    Lu Wang et al, 2024, Front. Oncol. CrossRef
  36. Mesenchymal stem cells—role in tuberculosis pathogenesis and persistence
    Sapna Bajeli et al, 2024 CrossRef
  37. The role of the neurotrophin network in skin squamous cell cancer and the novel use of the zebrafish system
    Marika Quadri et al, 2024, JID Innovations CrossRef
  38. PRRX1 silencing is required for metastatic outgrowth in melanoma and is an independent prognostic of reduced survival in patients
    Josep R. Ferreres et al, 2024, Molecular Oncology CrossRef